20% surge in half a year: pharma sector profits from the free fall of chip stocks
The euphoria around artificial intelligence collided this week with the reality of interest rates and financing costs, wiping out about $2 trillion from the value of U.S. chip companies. While short sellers raked in over…
Assessment
Investors are rotating out of AI and chip stocks into pharma after a brutal week erased about 2 trillion dollars in U.S. chip company value. Short sellers pocketed over 32 billion dollars on paper as panic spread to software and cybersecurity shares. The 20 percent pharma sector jump in six months shows where capital is fleeing when rate and financing cost realities hit speculative tech. Watch whether this rotation holds or reverses if chip valuations stabilize.